Emergent Bio climbs out of BOTTOM TEN with CureVac sliding in. Strongest performer for the week was Vir, increasing its overall gain by 25%, now down just 15% from March 1 up from a loss of 40% last week.
Atara and CureVac were the only two to lose ground.
No comments:
Post a Comment